Age-related increase in alanine aminotransferase correlates with elevated levels of plasma amino acids, decanoylcarnitine, lp-pla2 activity, oxidative stress, and arterial stiffness

Journal of Proteome Research

Volumn 13, Issue 7, 2014, Pages 3467-3475

  Jung, Saem ^a   Kim, Oh Yoen ^b   Kim, Minjoo ^a   Song, Juheui ^a   Lee, Sang Hyun ^c   Lee, Jong Ho ^a  

^a Yonsei University   (South Korea)

^b Dong A University   (South Korea)

^c National Health Insurance Corporation   (South Korea)

Author keywords

alanine aminotransferase; arterial stiffness; aspartate aminotransferase; cardiovascular risk factors; decanoylcarnitine; l leucine; l phenylalanine; l valine; Plasma metabolites

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ALANINE AMINOTRANSFERASE; AMINO ACID DERIVATIVE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARNITINE DERIVATIVE; FATTY ACID; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; LEUCINE; OXIDIZED LOW DENSITY LIPOPROTEIN; PHENYLALANINE; TUMOR NECROSIS FACTOR ALPHA; VALINE; AMINO ACID; BIOLOGICAL MARKER; CARNITINE; DECANOYLCARNITINE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ARTERIAL STIFFNESS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; BODY MASS; BRACHIAL ANKLE PULSE WAVE VELOCITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLITE; NUTRITIONAL ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; WAIST CIRCUMFERENCE; AGING; ANALOGS AND DERIVATIVES; BLOOD; MIDDLE AGED;

ADULT; AGED; AGING; ALANINE TRANSAMINASE; AMINO ACIDS; BIOLOGICAL MARKERS; CARNITINE; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; VASCULAR STIFFNESS;

EID: 84903736192     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500422z     Document Type: Article

References (36)

1. Chang, Y.; Ryu, S.; Sung, E.; Jang, Y. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease Clin. Chem. 2007, 53 (4) 686-92
2. Wannamethee, S. G.; Shaper, A. G.; Lennon, L.; Whincup, P. H. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men Diabetes Care 2005, 28 (12) 2913-18
3. Sattar, N.; Scherbakova, O.; Ford, I.; OReilly, D. S.; Stanley, A.; Forrest, E.; Macfarlane, P. W.; Packard, C. J.; Cobbe, S. M.; Shepherd, J. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study Diabetes 2004, 53 (11) 2855-60
4. Kim, H. C.; Nam, C. M.; Jee, S. H.; Han, K. H.; Oh, D. K.; Suh, I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study BMJ 2004, 328 (7446) 983
5. Ghouri, N.; Preiss, D.; Sattar, N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data Hepatology 2010, 52 (3) 1156-61
6. Tiikkainen, M.; Bergholm, R.; Vehkavaara, S.; Rissanen, A.; Häkkinen, A. M.; Tamminen, M.; Teramo, K.; Yki-Järvinen, H. Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content Diabetes 2003, 52 (3) 701-7
7. Dong, M. H.; Bettencourt, R.; Barrett-Connor, E.; Loomba, R. Alanine aminotransferase decreases with age: the Rancho Bernardo Study PloS One 2010, 5 (12) e14254
8. Prati, D.; Taioli, E.; Zanella, A.; Della Torre, E.; Butelli, S.; Del Vecchio, E.; Vianello, L.; Zanuso, F.; Mozzi, F.; Milani, S.; Conte, D.; Colombo, M.; Sirchia, G. Updated definitions of healthy ranges for serum alanine aminotransferase levels Ann. Int. Med. 2002, 137 (1) 1-10
9. Hunt, C. M.; Papay, J. I.; Edwards, R. I.; Theodore, D.; Alpers, D. H.; Dollery, C.; Debruin, T. W.; Adkison, K. K.; Stirnadel, H. A.; Gibbs, T. G. Monitoring liver safety in drug development: the GSK experience Regul. Toxicol. Pharmacol. 2007, 49 (2) 90-100
10. Li, M.; Wang, B.; Zhang, M.; Rantalainen, M.; Wang, S.; Zhou, H.; Zhang, Y.; Shen, J.; Pang, X.; Zhang, M.; Wei, H.; Chen, Y.; Lu, H.; Zuo, J.; Su, M.; Qiu, Y.; Jia, W.; Xiao, C.; Smith, L. M.; Yang, S.; Holmes, E.; Tang, H.; Zhao, G.; Nicholson, J. K.; Li, L.; Zhao, L. Symbiotic gut microbes modulate human metabolic phenotypes Proc. Natl. Acad. Sci. U.S.A. 2008, 105 (6) 2117-22
11. 4-and ω-naphthylisothiocyanate-induced animal models: Quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry Chem. Res. Toxicol. 2008, 21 (12) 2280-88
12. Wilensky, R. L.; Shi, Y.; Mohler, E. R.; Hamamdzic, D.; Burgert, M. E.; Li, J.; Postle, A.; Fenning, R. S.; Bollinger, J. G.; Hoffman, B. E.; Pelchovitz, D. J.; Yang, J.; Mirabile, R. C.; Webb, C. L.; Zhang, L.; Zhang, P.; Gelb, M. H.; Walker, M. C.; Zalewski, A.; Macphee, C. H. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development Nat. Med. 2008, 14 (10) 1059-66
13. Kim, O. Y.; Yoe, H. Y.; Kim, H. J.; Park, J. Y.; Kim, J. Y.; Lee, S. H.; Lee, J. H.; Lee, K. P.; Jang, Y.; Lee, J. H. Independent inverse relationship between serum lycopene concentration and arterial stiffness Atherosclerosis 2010, 208 (2) 581-86
14. Wolfram, R.; Oguogho, A.; Palumbo, B.; Sinzinger, H. Enhanced oxidative stress in coronary heart disease and chronic heart failure as indicated by an increased 8-epi-PGF2ω Eur. J. Heart Failure 2005, 7 (2) 167-72
15. Vassalle, C.; Petrozzi, L.; Botto, N.; Andreassi, M. G.; Zucchelli, G. C. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors J. Intern. Med. 2004, 256 (4) 308-15
16. Tomiyama, H.; Yamashina, A. Non-invasive vascular function tests: their pathophysiological background and clinical application Circ. J. 2010, 74 (1) 24-33
17. Tsuchikura, S.; Shoji, T.; Kimoto, E.; Shinohara, K.; Hatsuda, S.; Koyama, H.; Emoto, M.; Nishizawa, Y. Brachial-ankle pulse wave velocity as an index of central arterial stiffness J. Atheroscler. Thromb. 2010, 17 (6) 658-65
18. Marchesini, G.; Brizi, M.; Morselli-Labate, A. M.; Bianchi, G.; Bugianesi, E.; McCullough, A. J.; Forlani, G.; Melchionda, N. Association of nonalcoholic fatty liver disease with insulin resistance Am. J. Med. 1999, 107 (5) 450-55
19. Day, C. P.; James, O. F. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998, 114 (4) 842-45
20. Hamaguchi, M.; Kojima, T.; Takeda, N.; Nakagawa, T.; Taniguchi, H.; Fujii, K.; Omatsu, T.; Nakajima, T.; Sarui, H.; Shimazaki, M.; Kato, T.; Okuda, J.; Ida, K. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease Ann. Int. Med. 2005, 143 (10) 722-28
21. Clark, J. M.; Brancati, F. L.; Diehl, A. M. The prevalence and etiology of elevated aminotransferase levels in the United States Am. J. Gastroenterol. 2003, 98 (5) 960-7
22. Stephens, F. B.; Constantin-Teodosiu, D.; Greenhaff, P. L. New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle J. Physiol. 2007, 581 (2) 431-44
23. Ramos-Roman, M. A.; Sweetman, L.; Valdez, M. J.; Parks, E. J. Postprandial changes in plasma acylcarnitine concentrations as markers of fatty acid flux in overweight and obesity Metabolism 2012, 61 (2) 202-12
24. Mai, M.; Tönjes, A.; Kovacs, P.; Stumvoll, M.; Fiedler, G. M.; Leichtle, A. B. Serum levels of acylcarnitines are altered in prediabetic conditions PloS One 2013, 8 (12) e82459
25. Swierczynski, J.; Sledzinski, T.; Slominska, E.; Smolenski, R.; Sledzinski, Z. Serum phenylalanine concentration as a marker of liver function in obese patients before and after bariatric surgery Obes. Surg. 2009, 19 (7) 883-89
26. Kalhan, S. C.; Guo, L.; Edmison, J.; Dasarathy, S.; McCullough, A. J.; Hanson, R. W.; Milburn, M. Plasma metabolomic profile in nonalcoholic fatty liver disease Metabolism 2011, 60 (3) 404-13
27. Newgard, C. B.; An, J.; Bain, J. R.; Muehlbauer, M. J.; Stevens, R. D.; Lien, L. F.; Haqq, A. M.; Shah, S. H.; Arlotto, M.; Slentz, C. A.; Rochon, J.; Gallup, D.; Ilkayeva, O.; Wenner, B. R.; Yancy, W. E.; Eisenson, H.; Musante, G.; Surwit, R.; Millington, D. S.; Butler, M. D.; Svetkey, L. P. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance Cell Metab. 2009, 9 (4) 311-26
28. Feng, L. M.; Feng, G. F.; Chen, Y. Evaluation of lipoprotein-associated phospholipase A2 in healthy Chinese han adult Serum Lipids Health Dis. 2014, 13 (1) 6
29. Fraser, A.; Harris, R.; Sattar, N.; Ebrahim, S.; Smith, G. D.; Lawlor, D. A. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British womens heart and health study and meta-analysis Arterioscler. Thromb. Vasc. Biol. 2007, 27 (12) 2729-35
30. Patel, D. A.; Srinivasan, S. R.; Xu, J. H.; Chen, W.; Berenson, G. S. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa heart study Metabolism 2007, 56 (6) 792-798
31. Zalewski, A.; Macphee, C. Role of lipoprotein-associated phospholipase A2 in atherosclerosis biology, epidemiology, and possible therapeutic target Arterioscler. Thromb. Vasc. Biol. 2005, 25 (5) 923-31
32. Tarbet, E. B.; Stafforini, D. M.; Elstad, M. R.; Zimmerman, G. A.; McIntyre, T. M.; Prescott, S. M. Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase J. Biol. Chem. 1991, 266 (25) 16667-73
33. Kono, N.; Inoue, T.; Yoshida, Y.; Sato, H.; Matsusue, T.; Itabe, H.; Niki, E.; Aoki, J.; Arai, H. Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo J. Biol. Chem. 2008, 283 (3) 1628-36
34. Stafforini, D. M.; Sheller, J. R.; Blackwell, T. S.; Sapirstein, A.; Yull, F. E.; McIntyre, T. M.; Bonventre, J. V.; Prescott, S. M.; Roberts, L. J. Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases J. Biol. Chem. 2006, 281 (8) 4616-23
35. Kono, N.; Inoue, T.; Yoshida, Y.; Sato, H.; Matsusue, T.; Itabe, H.; Niki, E.; Aoki, J.; Arai, H. Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo J. Biol. Chem. 2008, 283 (3) 1628-36
36. Skoog, T.; Dichtl, W.; Boquist, S.; Skoglund-Andersson, C.; Karpe, F.; Tang, R.; Bond, M. G.; de Faire, U.; Nilsson, J.; Eriksson, P.; Hamsten, A. Plasma tumour necrosis factor-ω and early carotid atherosclerosis in healthy middle-aged men Eur. Heart J. 2002, 23 (5) 376-83